TABLE 5.

Clinical outcomes for patients with treatment-emergent virus isolates with reduced drug susceptibility

Parameter	All placeboa	All pleconarilb	Reduced drug susceptibility
No. of patients	380	364	28
Duration of illness (median no. of days [95% CIc])	7.4 (6.9-7.9)	6.3 (5.8-6.8)	4.4 (2.9-6.0)

^aRepresents all placebo-treated subjects with baseline virus culture-positive samples for which valid EC₅₀ values were obtained.

^bRepresents all pleconaril-treated subjects with baseline virus culture-positive samples for which valid EC₅₀ values were obtained.

^cCI, confidence interval.